Dr. Neena Kapoor, MD
Claim this profileChildren's Hospital Los Angeles
Studies Aplastic Anemia
Studies Acute Lymphoblastic Leukemia
12 reported clinical trials
22 drugs studied
Area of expertise
1Aplastic Anemia
HLA-A positive
HLA-A negative
HLA positive
2Acute Lymphoblastic Leukemia
HLA-A positive
HLA-A negative
HLA positive
Affiliated Hospitals
Clinical Trials Neena Kapoor, MD is currently running
Tabelecleucel
for Post-Transplant Cancer
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab and rituximab plus chemotherapy or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.
Recruiting2 awards Phase 312 criteria
T Cell-Depleted Stem Cell Transplant
for Leukemia
This phase II trial studies how well naive T-cell depletion works in preventing chronic graft-versus-host disease in children and young adults with blood cancers undergoing donor stem cell transplant. Sometimes the transplanted white blood cells from a donor attack the body's normal tissues (called graft versus host disease). Removing a particular type of T cell (naive T cells) from the donor cells before the transplant may stop this from happening.
Recruiting1 award Phase 222 criteria
More about Neena Kapoor, MD
Clinical Trial Related6 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Neena Kapoor, MD has experience with
- Busulfan
- Nomacopan (rVA576)
- Unlicensed Cryopreserved Cord Blood Units
- Cell Processing For TCRαβ+/CD19+ Depletion
- Donor Search Prognosis Score
- Autologous CD34+ HSC Cells Transduced With The Lentiviral Vector Containing A ShRNA Targeting BCL11a
Breakdown of trials Neena Kapoor, MD has run
Aplastic Anemia
Acute Lymphoblastic Leukemia
Leukemia
Lymphoblastic Leukemia-Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Neena Kapoor, MD specialize in?
Neena Kapoor, MD focuses on Aplastic Anemia and Acute Lymphoblastic Leukemia. In particular, much of their work with Aplastic Anemia has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Neena Kapoor, MD currently recruiting for clinical trials?
Yes, Neena Kapoor, MD is currently recruiting for 8 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Neena Kapoor, MD has studied deeply?
Yes, Neena Kapoor, MD has studied treatments such as Busulfan, nomacopan (rVA576), Unlicensed Cryopreserved Cord Blood Units.
What is the best way to schedule an appointment with Neena Kapoor, MD?
Apply for one of the trials that Neena Kapoor, MD is conducting.
What is the office address of Neena Kapoor, MD?
The office of Neena Kapoor, MD is located at: Children's Hospital Los Angeles, Los Angeles, California 90027 United States. This is the address for their practice at the Children's Hospital Los Angeles.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.